EDIGEN Trademark

Trademark Overview

On Sunday, November 5, 2017, a trademark application was filed for EDIGEN with the United States Patent and Trademark Office. The USPTO has given the EDIGEN trademark a serial number of 87672570. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 10, 2022. This trademark is owned by EDIGENE INC. The EDIGEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Pharmaceutical preparations in the nature of genetically modified therapeuticpharmaceuticals, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; Cells for medical or clinical use; Diagnostic reagents for medicinal use
edigen

General Information

Serial Number87672570
Word MarkEDIGEN
Filing DateSunday, November 5, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Pharmaceutical preparations in the nature of genetically modified therapeuticpharmaceuticals, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; Cells for medical or clinical use; Diagnostic reagents for medicinal use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEDIGENE INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBEIJING 102206
CN
Party NameEDIGENE INC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBEIJING 102206
CN

Trademark Events

Event DateEvent Description
Monday, January 10, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, May 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 13, 2021EXTENSION 5 GRANTED
Monday, May 10, 2021EXTENSION 5 FILED
Monday, May 10, 2021TEAS EXTENSION RECEIVED
Tuesday, December 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, November 29, 2020EXTENSION 4 GRANTED
Sunday, November 29, 2020EXTENSION 4 FILED
Sunday, November 29, 2020TEAS EXTENSION RECEIVED
Tuesday, June 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 29, 2020EXTENSION 3 GRANTED
Friday, May 29, 2020EXTENSION 3 FILED
Friday, May 29, 2020TEAS EXTENSION RECEIVED
Wednesday, April 15, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, March 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, March 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, March 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, March 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2019EXTENSION 2 GRANTED
Monday, November 11, 2019EXTENSION 2 FILED
Monday, November 11, 2019TEAS EXTENSION RECEIVED
Tuesday, May 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 10, 2019EXTENSION 1 GRANTED
Friday, May 10, 2019EXTENSION 1 FILED
Friday, May 10, 2019TEAS EXTENSION RECEIVED
Sunday, March 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 6, 2019ASSIGNED TO EXAMINER
Tuesday, December 4, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 27, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 9, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 9, 2018LETTER OF SUSPENSION E-MAILED
Thursday, August 9, 2018SUSPENSION LETTER WRITTEN
Wednesday, August 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 8, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 6, 2018ASSIGNED TO LIE
Wednesday, July 18, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 12, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 12, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 13, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 13, 2018NON-FINAL ACTION E-MAILED
Tuesday, February 13, 2018NON-FINAL ACTION WRITTEN
Tuesday, February 13, 2018ASSIGNED TO EXAMINER
Wednesday, November 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, November 8, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

edigen preparations nature pharmaceutical dysfunction tissue modified genetically diabetes therapeuticpharmaceuticals antifungal